Log in

OTCMKTS:SKBI - Skystar Bio-Pharmaceutical Stock Price, Forecast & News

Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume25 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta-175.12
Skystar Bio-Pharmaceutical Company researches, develops, produces, markets, and sells veterinary healthcare and medical care products in the People's Republic of China. The company offers micro-organism products, veterinary medicines for poultry and livestock, feed additives, and bio-pharmaceutical veterinary vaccines. It markets its products through distributers and franchise distributors, as well as directly to customers. The company is headquartered in Xi'an, the People's Republic of China.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:SKBI
Previous SymbolNASDAQ:SKBI
CUSIPN/A
Phone86-29-8819-3188

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees318
Next Earnings DateN/A
OptionableNot Optionable

Receive SKBI News and Ratings via Email

Sign-up to receive the latest news and ratings for SKBI and its competitors with MarketBeat's FREE daily newsletter.


Skystar Bio-Pharmaceutical (OTCMKTS:SKBI) Frequently Asked Questions

What is Skystar Bio-Pharmaceutical's stock symbol?

Skystar Bio-Pharmaceutical trades on the OTCMKTS under the ticker symbol "SKBI."

Has Skystar Bio-Pharmaceutical been receiving favorable news coverage?

Media headlines about SKBI stock have trended positive this week, according to InfoTrie. The research firm identifies negative and positive media coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Skystar Bio-Pharmaceutical earned a daily sentiment score of 2.4 on InfoTrie's scale. They also assigned media headlines about the healthcare company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Skystar Bio-Pharmaceutical.

Who are some of Skystar Bio-Pharmaceutical's key competitors?

What other stocks do shareholders of Skystar Bio-Pharmaceutical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Skystar Bio-Pharmaceutical investors own include XOMA (XOMA), Uranium Energy (UEC), Abraxas Petroleum (AXAS), CTI BioPharma (CTIC), Gulf Resources (GURE), Inovio Pharmaceuticals (INO), Opko Health (OPK), Rexahn Pharmaceuticals (REXN), SciClone Pharmaceuticals (SCLN) and China Green Agriculture (CGA).

Who are Skystar Bio-Pharmaceutical's key executives?

Skystar Bio-Pharmaceutical's management team includes the folowing people:
  • Mr. Weibing Lu, Chairman and Chief Exec. Officer (Age 56)

How do I buy shares of Skystar Bio-Pharmaceutical?

Shares of SKBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Skystar Bio-Pharmaceutical's official website?

The official website for Skystar Bio-Pharmaceutical is http://www.skystarbio-pharmaceutical.com/.

How can I contact Skystar Bio-Pharmaceutical?

Skystar Bio-Pharmaceutical's mailing address is RM 10601 JIEZUO PLAZA NO. 4 FENGHUI ROAD SOUTH, XIAN F4, . The healthcare company can be reached via phone at 86-29-8819-3188 or via email at [email protected]


MarketBeat Community Rating for Skystar Bio-Pharmaceutical (OTCMKTS SKBI)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  60 (Vote Outperform)
Underperform Votes:  69 (Vote Underperform)
Total Votes:  129
MarketBeat's community ratings are surveys of what our community members think about Skystar Bio-Pharmaceutical and other stocks. Vote "Outperform" if you believe SKBI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SKBI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/13/2019 by MarketBeat.com Staff

Featured Article: Trading Strategy

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel